This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Criteria used to ensure the validity of primary studies
The authors did not report any explicit criteria for ensuring the validity of the primary studies. However, only evidence from randomised trials was used, thus implying that the primary studies had high internal validity.
Methods used to judge relevance and validity, and for extracting data
Not stated.
Number of primary studies included
Only 3 studies were included in the review.
Methods of combining primary studies
When the authors had to combine the primary study estimates, conservative values (disfavouring coated CVCs) were selected.
Investigation of differences between primary studies
Results of the review
The incidence of CRBSIs with standard CVC was 3.3% (range: 1.65 -4.95).
The RRR for CRBSIs with CCS-CVC versus standard CVC was 60% (range: 30 -90).
The RRR for CRBSIs with RM-CVC versus standard CVC was 85% (range: 42.5 -92.5).
Measure of benefits used in the economic analysis
The measure of benefits used in the economic analysis was the number of cases of CRBSIs prevented with each CVC. This measure was obtained from the decision model.
Direct costs
The costs were incurred in the short term and, appropriately, no discounting was applied. The unit costs were reported separately from the quantities of resources used. The cost categories included in the analysis were devices and CRBSI (diagnosis, treatment and prolonged hospitalisation). The perspective of the study was that of a large third-party payer (or institution). The source of the cost data was the average prices of CVC devices and institutional charges for CRBSI. Such charges were then converted into actual costs using a department-specific cost-to-charge ratio. The authors made assumptions, supported with published data, to estimate resource use. Whenever possible, conservative assumptions were made. All the costs were reported in 2002 values.
